Literature DB >> 25799203

Evidence-based deprescribing of statins in patients with advanced illness.

Holly M Holmes1, Adam Todd2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25799203      PMCID： PMC4420700          DOI： 10.1001/jamainternmed.2015.0328

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  6 in total

1.  Statin discontinuation in nursing home residents with advanced dementia.

Authors:  Jennifer Tjia; Sarah L Cutrona; Daniel Peterson; George Reed; Susan E Andrade; Susan L Mitchell
Journal:  J Am Geriatr Soc       Date:  2014-11-04       Impact factor: 5.562

2.  Reducing inappropriate polypharmacy: the process of deprescribing.

Authors:  Ian A Scott; Sarah N Hilmer; Emily Reeve; Kathleen Potter; David Le Couteur; Deborah Rigby; Danijela Gnjidic; Christopher B Del Mar; Elizabeth E Roughead; Amy Page; Jesse Jansen; Jennifer H Martin
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

3.  Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.

Authors:  Jean S Kutner; Patrick J Blatchford; Donald H Taylor; Christine S Ritchie; Janet H Bull; Diane L Fairclough; Laura C Hanson; Thomas W LeBlanc; Greg P Samsa; Steven Wolf; Noreen M Aziz; David C Currow; Betty Ferrell; Nina Wagner-Johnston; S Yousuf Zafar; James F Cleary; Sandesh Dev; Patricia S Goode; Arif H Kamal; Cordt Kassner; Elizabeth A Kvale; Janelle G McCallum; Adeboye B Ogunseitan; Steven Z Pantilat; Russell K Portenoy; Maryjo Prince-Paul; Jeff A Sloan; Keith M Swetz; Charles F Von Gunten; Amy P Abernethy
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

4.  Statin prescribing patterns in a cohort of cancer patients with poor prognosis.

Authors:  Elizabeth A Bayliss; Michael R Bronsert; Liza M Reifler; Jennifer L Ellis; John F Steiner; Deanna B McQuillen; Diane L Fairclough
Journal:  J Palliat Med       Date:  2013-01-10       Impact factor: 2.947

5.  Application of new cholesterol guidelines to a population-based sample.

Authors:  Michael J Pencina; Ann Marie Navar-Boggan; Ralph B D'Agostino; Ken Williams; Benjamin Neely; Allan D Sniderman; Eric D Peterson
Journal:  N Engl J Med       Date:  2014-03-19       Impact factor: 91.245

6.  Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkage.

Authors:  Efty P Stavrou; Nicholas Buckley; Jake Olivier; Sallie-Anne Pearson
Journal:  BMJ Open       Date:  2012-05-21       Impact factor: 2.692
  6 in total
  14 in total

1.  All, some or none? Statin prescribing for frail older adults.

Authors:  Sudeep S Gill
Journal:  CMAJ       Date:  2019-01-14       Impact factor: 8.262

2.  Outcomes of deprescribing interventions in older patients with life-limiting illness and limited life expectancy: A systematic review.

Authors:  Shakti Shrestha; Arjun Poudel; Kathryn Steadman; Lisa Nissen
Journal:  Br J Clin Pharmacol       Date:  2019-12-12       Impact factor: 4.335

Review 3.  Statins for Primary Prevention in Those Aged 70 Years and Older: A Critical Review of Recent Cholesterol Guidelines.

Authors:  Chelsea E Hawley; John Roefaro; Daniel E Forman; Ariela R Orkaby
Journal:  Drugs Aging       Date:  2019-08       Impact factor: 3.923

4.  Perceptions of Statin Discontinuation among Patients with Life-Limiting Illness.

Authors:  Jennifer Tjia; Jean S Kutner; Christine S Ritchie; Patrick J Blatchford; Rachael E Bennett Kendrick; Maryjo Prince-Paul; Tamara J Somers; Mary Lynn McPherson; Jeff A Sloan; Amy P Abernethy; Jon P Furuno
Journal:  J Palliat Med       Date:  2017-05-18       Impact factor: 2.947

Review 5.  The Role of Deprescribing in Older Adults with Chronic Kidney Disease.

Authors:  Laura K Triantafylidis; Chelsea E Hawley; Laura P Perry; Julie M Paik
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

Review 6.  Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review.

Authors:  Sujita W Narayan; Prasad S Nishtala
Journal:  Drugs Aging       Date:  2017-10       Impact factor: 3.923

7.  Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.

Authors:  Andrew Whitman; Kathlene DeGregory; Amy Morris; Supriya Mohile; Erika Ramsdale
Journal:  Support Care Cancer       Date:  2018-06-04       Impact factor: 3.603

8.  A prototype for evidence-based pharmaceutical opinions to promote physician-pharmacist communication around deprescribing.

Authors:  Philippe Martin; Cara Tannenbaum
Journal:  Can Pharm J (Ott)       Date:  2018-02-08

9.  General Practitioners' Decision Making about Primary Prevention of Cardiovascular Disease in Older Adults: A Qualitative Study.

Authors:  Jesse Jansen; Shannon McKinn; Carissa Bonner; Les Irwig; Jenny Doust; Paul Glasziou; Katy Bell; Vasi Naganathan; Kirsten McCaffery
Journal:  PLoS One       Date:  2017-01-13       Impact factor: 3.240

10.  The support of medication reviews in hospitalised patients using a clinical decision support system.

Authors:  Hugo A J M de Wit; Kim P G M Hurkens; Carlota Mestres Gonzalvo; Machiel Smid; Walther Sipers; Bjorn Winkens; Wubbo J Mulder; Rob Janknegt; Frans R Verhey; Paul-Hugo M van der Kuy; Jos M G A Schols
Journal:  Springerplus       Date:  2016-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.